Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
In this section, we usually try to help investors determine whether New You is trading at an attractive price based on the cash flow it is expected to produce in the future. But as New You has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.
Show me the analysis anyway
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
New You. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
New You's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as New You has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare New You's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare New You's earnings growth to the United States of America market average as no estimate data is available.
Unable to compare New You's revenue growth to the United States of America market average as no estimate data is available.
Unable to determine if New You is high growth as no earnings estimate data is available.
Unable to determine if New You is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access New You's filings and announcements here.
New You's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Raymond W. Grimm, Jr., also known as Ray, has been Advisor of Laguna Blends Inc. since May 2017. He is Co-Founder of New You Inc. He serves as the Chief Executive Officer since 2018 at New You Inc. and serves as its Chairman of the Board. Mr. Grimm serves as the Chief Executive Officer and Chairman of BIOPRO Technology. Mr. Grimm is the Founder, Chairman of the Board, Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer at ACTIS Global Ventures, Inc. Mr. Grimm served as the President of Laguna Blends Inc. since May 2, 2016 until May 2017 and served as its Chief Executive Officer and Director since December 16, 2016 until May 2017. Mr. Grimm served as Chief Executive Officer, Acting Chief Financial Officer, Principal Accounting Officer and at New Paltz Capital Corporation. He is a seasoned and highly regarded executive in the Direct Selling Industry with a track record that includes the successful launch of three companies, each achieving over $50 million in annual sales within their first five years. He was served as a President of Isodiol International Inc. from May 2, 2016 to May 10, 2017 and served as its CEO and a director from December 16, 2016 to May 10, 2017. He was Co-founder and CEO from 2009-2010 at Cal Nutrisciences (sold to Xyngular, Inc.). Mr. Grimm served as President of Body Wise International from 1989 to 1999. He was CEO from 1987-1988 at Univite, Inc. He has been Chairman of ACTIS Global Ventures and has been its Director since 2002. He has been consultant and Member of Advisory Board at Laguna Blends Inc. since January 2016. From September 1999 to March 2002, he served as Direct sales industry Consultant and assisted in the launch of Orenda International, a direct sales nutritional distribution company. Mr. Grimm served as a Director of Dickie Walker Marine Inc. He also served as President of Childhelp’s California State Board. He is a proud member of the DSA (Direct Selling Association) and founding member and current member of the MLMIA (Multilevel Marketing International Association).
Insufficient data for Ray to compare compensation growth.
Ray's remuneration is lower than average for companies of similar size in United States of America.
Chief Accounting Officer
Board of Directors
Member of Athletic Advisory Board
Member of Athletic Advisory Board
Who owns this company?
Recent Insider Trading
No 3 month open market individual insider trading information.
New You, Inc., through its subsidiary, New You LLC, develops and markets cannabidiol (CBD) hemp oil-based products. The company offers DROPS, a canna-active CBD beverage enhancer; CB2 & CBD 2 Plus, a multi spectrum hemp-extracted CBD and hops-extracted beta-caryophyllene; Drops for pets; Caffe Canna, an organic cannabinoid-infused non-gmo dark roast coffee to promote weight loss; and ABSORB, a product that tells stomach not hungry. It also provides RELEASE, a product to remove the belly bloat, constipation, and the toxic build-up in the wrong places; Drops FX, a product to provide the user with an energy boost with blend of canna-active vitamins B3, B6, B9, and B12; and Drops FX Sleep, a product to help the user gets the sleep. The company markets and sells its products through multi-level marketing and direct sales force to independent business owners. New You, Inc. is based in Carlsbad, California.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.